ClinicalTrials.govpublic full text
Patient-Reported AutoImmunity Secondary to Cancer immunothErapy
opportunistic autoimmune diseases, monoclonal anti-pd-1 immunotherapy, monoclonal anti-ctla-4 immunotherapy, checkpoint inhibitors, autoimmune manifestations, patient reported outcome, oncology, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889039
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.